DOYLE MITTIE (Chief Medical Officer) sold 96.8% of their position (108.23K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.23M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+1K
Price / share
$12.65
Trade value
$12.65K
% of position
Common Stock
Shares
+679.00
Price / share
$8.04
Trade value
$5.46K
% of position
Common Stock
Shares
−1.68K
Price / share
$16.00
Trade value
$26.86K
% of position
Common Stock
Shares
+77.91K
Price / share
$12.65
Trade value
$985.50K
% of position
Common Stock
Shares
+28.65K
Price / share
$8.04
Trade value
$230.35K
% of position
Common Stock
Shares
−27.54K
Price / share
$18.03
Trade value
$496.41K
% of position
Common Stock
Shares
−5K
Price / share
$19.65
Trade value
$98.25K
% of position
Common Stock
Shares
−44.94K
Price / share
$21.20
Trade value
$952.67K
% of position
Common Stock
Shares
−19.02K
Price / share
$22.41
Trade value
$426.05K
% of position
Common Stock
Shares
−10.06K
Price / share
$22.88
Trade value
$230.13K
% of position
Net shares
+0.00
Net value
-$996.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2026 | M · Option Exercise | +1K | $12.65 | $12.65K | 27.6% | 3.62K | 4.62K |
| Common Stock Direct | 5/5/2026 | M · Option Exercise | +679.00 | $8.04 | $5.46K | 14.7% | 4.62K | 5.30K |
| Common Stock Direct | 5/5/2026 | S · Sale | −1.68K | $16.00 | $26.86K | 31.7% | 5.30K | 3.62K |
| Common Stock Direct | 5/6/2026 | M · Option Exercise | +77.91K | $12.65 | $985.50K | 2150.9% | 3.62K | 81.53K |
| Common Stock Direct | 5/6/2026 | M · Option Exercise | +28.65K | $8.04 | $230.35K | 35.1% | 81.53K | 110.18K |
| Common Stock Direct | 5/6/2026 | S · Sale | −27.54K | $18.03 | $496.41K | 25.0% | 110.18K | 82.64K |
| Common Stock Direct | 5/6/2026 | S · Sale | −5K | $19.65 | $98.25K | 6.1% | 82.64K | 77.64K |
| Common Stock Direct | 5/6/2026 | S · Sale | −44.94K | $21.20 | $952.67K | 57.9% | 77.64K | 32.70K |
| Common Stock Direct | 5/6/2026 | S · Sale | −19.02K | $22.41 | $426.05K | 58.2% | 32.70K | 13.68K |
| Common Stock Direct | 5/6/2026 | S · Sale | −10.06K | $22.88 | $230.13K | 73.5% | 13.68K | 3.62K |
| Total | +0.00 | -$996.41K | ||||||
Stock Option (Right to Buy)
Common Stock
1K shares
Shares
−1K
Strike price
12.65
Held after
209.53K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
679.00 shares
Shares
−679.00
Strike price
8.04
Held after
147.65K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
77.91K shares
Shares
−77.91K
Strike price
12.65
Held after
131.63K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
28.65K shares
Shares
−28.65K
Strike price
8.04
Held after
119K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1K shares | 5/5/2026 | M · Option Exercise | −1K | 12.65 | — | 209.53K |
| Stock Option (Right to Buy) Direct | Common Stock679.00 shares | 5/5/2026 | M · Option Exercise | −679.00 | 8.04 | — | 147.65K |
| Stock Option (Right to Buy) Direct | Common Stock77.91K shares | 5/6/2026 | M · Option Exercise | −77.91K | 12.65 | — | 131.63K |
| Stock Option (Right to Buy) Direct | Common Stock28.65K shares | 5/6/2026 | M · Option Exercise | −28.65K | 8.04 | — | 119K |